Clinical Trials Browser

Phase 1/2 × INDUSTRY × CCT239065 × Clear all

NCT05102292 2023-08-21

The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation

Phase 1/2 Unknown

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic